Literature DB >> 21518594

Association between non-alcoholic fatty liver disease and coronary artery disease severity.

Ling Sun1, Shu-zheng Lü.   

Abstract

BACKGROUND: Both non-alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD) are closely associated with many metabolic disorders. Invasive coronary angiography (CAG) is a common approach as an intervention for CAD. However, the association between angiographic severity of coronary artery and NAFLD remains controversial. This study aimed to evaluate the relationship between NAFLD and CAD.
METHODS: Totally 542 consecutive patients who planned to undergo CAG due to a suspected CAD were enrolled. Abdominal computed tomography (CT) was performed before angiography to detect NAFLD. CAD was defined as stenosis of at least 50% in at least one major coronary artery. The severity of CAD was assessed by the number of vessels affected and the vessel score multiplied by the severity score (Gensini score). Significant stenosis was defined as 70% or greater reduction in lumen diameter. A probability value of P < 0.05 was considered statistically significant.
RESULTS: Of 542 patients studied, 248 (45.8%) were found to have NAFLD by abdominal CT, and 382 patients (88%) were found to have significant CAD by CAG. Age, diabetes mellitus, waist circumference, body mass index, and obesity were associated with NAFLD. According to the results of Logistic regression analysis, the presence of NAFLD independently increased the risk for CAD, as seen in CAG (odds ratio (OR), 95% confidence interval (CI): 7.585 (4.617-12.461); P < 0.001). NAFLD was significantly more common in patients as CAD severity increased (P < 0.001).
CONCLUSIONS: The presence of NAFLD is associated with high severity of CAD, requiring that patients with abdominal obesity be also investigated for NAFLD. Patients with NAFLD should be closely followed up for the presence and severity of CAD.

Entities:  

Mesh:

Year:  2011        PMID: 21518594

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  14 in total

1.  High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.

Authors:  Stefan B Puchner; Michael T Lu; Thomas Mayrhofer; Ting Liu; Amit Pursnani; Brian B Ghoshhajra; Quynh A Truong; Stephen D Wiviott; Jerome L Fleg; Udo Hoffmann; Maros Ferencik
Journal:  Radiology       Date:  2014-11-04       Impact factor: 11.105

2.  Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients.

Authors:  Roberta Eufrasia Ledda; Gianluca Milanese; Filippo Cademartiri; Erica Maffei; Giorgio Benedetti; Matteo Goldoni; Mario Silva; Nicola Sverzellati
Journal:  Radiol Med       Date:  2021-01-03       Impact factor: 3.469

Review 3.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

5.  Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease.

Authors:  Weihan Zhao; Lijuan Liu; Yunliang Wang; Tangyou Mao; Junxiang Li
Journal:  Exp Ther Med       Date:  2015-11-09       Impact factor: 2.447

6.  Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.

Authors:  Nilanka Perera; Jegarajah Indrakumar; Waruni Vijitha Abeysinghe; Vihangi Fernando; W M C K Samaraweera; Jayamal Sanjaya Lawrence
Journal:  BMC Cardiovasc Disord       Date:  2016-02-12       Impact factor: 2.298

Review 7.  Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.

Authors:  Shunquan Wu; Fuquan Wu; Yingying Ding; Jun Hou; Jingfeng Bi; Zheng Zhang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

8.  An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway.

Authors:  Tian-Hong Xie; Jun-Xiang Li; Tang-You Mao; Yi Guo; Chen Chen; Ya-Fei Han; Xiang Tan; Run-Hua Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-07       Impact factor: 2.629

9.  The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.

Authors:  Nicolette Veracruz; Bilal Hameed; Sammy Saab; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2020-05-20

Review 10.  The Wide and Complex Field of NAFLD Biomarker Research: Trends.

Authors:  Erika Wichro; Tanja Macheiner; Jasmin Schmid; Barbara Kavsek; Karine Sargsyan
Journal:  ISRN Hepatol       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.